As more federal funding began to flow to lupus research in the early 2000s, Congress tasked the National Institutes of Health (NIH) with establishing a way to ensure they were maximizing the impact of ...

The Lupus Foundation of America, Indiana Chapter is fortunate to have professionally-trained volunteers to offer support to lupus patients, friends, and family members throughout the state. These ...

Carla Day was diagnosed with lupus in January 1988. After struggling and persevering with the disease for over 30 years, she has dedicated her mission to helping others affected. Recognizing a need ...

Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe ...

Patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) may have an increased risk of dental decay and a higher oral bacteria presence. This study was published recently in BMC ...

Pericarditis recurrence in lupus is more likely — and has a dose-dependent relationship — with oral prednisone treatment, ...

Lupus is an autoimmune disease where the body's immune system attacks its own tissues and organs, causing inflammation and damaging organs. A new study has now shown that the natural active ...

After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...

New research suggests the use of oral prednisone should be limited in patients with systemic lupus erythematosus with a history of recurrent pericarditis.

Please provide your email address to receive an email when new articles are posted on . Patients on anifrolumab spent more time in remission and low disease activity, and reached those states more ...